NCT03987087 is a Phase 2 clinical trial of Radiation in Malignant Pleural Effusion, sponsored by Guizhou Medical University.

Who is sponsoring NCT03987087?

NCT03987087 is sponsored by Guizhou Medical University.

What drugs are being tested in NCT03987087?

Interventions in NCT03987087: Radiation, Chemotherapy.

What condition does NCT03987087 study?

NCT03987087 studies Malignant Pleural Effusion, Nonsmall Cell Lung Cancer, Stage IV.

Is NCT03987087 still recruiting?

NCT03987087 is currently status unknown. Last updated 14 June 2019.

Last reviewed 2019-06-14 · How we verify

NCT03987087

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC

Status unknown Phase 2 Last updated 14 June 2019

What this trial tests

Phase 2 trial testing Radiation in Malignant Pleural Effusion in 68 participants. Status unknown.

Timeline

1 September 2018

Primary endpoint
30 December 2020

30 December 2021

Quick facts

Lead sponsor	Guizhou Medical University
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	68
Start date	1 September 2018
Primary completion	30 December 2020
Estimated completion	30 December 2021
Sites	1 location across China

Drugs / interventions tested

Radiation
Chemotherapy (chemotherapy) — full drug profile →

Conditions studied

Malignant Pleural Effusion — all drugs for Malignant Pleural Effusion →
Nonsmall Cell Lung Cancer, Stage IV — all drugs for Nonsmall Cell Lung Cancer, Stage IV →

Sponsor

Guizhou Medical University

Who can join

Adults 18 to 80, any sex, with Malignant Pleural Effusion or Nonsmall Cell Lung Cancer, Stage IV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized phase II study compare survival outcomes and toxicity of malignant pleural effusion stage IV non small-cell lung cancer patients Intrapleural infusion chemotherapy in combination with concurrent thoracic radiation therapy (TRT) VS not combination with concurrent thoracic radiation therapy (TRT).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Radiation

Trials testing the same drug.

NCT07346196 — A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck · Phase 2 · not yet recruiting
NCT07141147 — A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Lo · NA · not yet recruiting
NCT06270888 — Hypofractionation (Radiation) Trial for Multiple Myeloma · Phase 1 · recruiting
NCT06875583 — The Radiation ProtEction for Dose RedUction in the Cardiac CathEter Lab Study: The REDUCE Trial · NA · recruiting
NCT07046221 — Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery · Phase 2 · not yet recruiting

Other recruiting trials for Malignant Pleural Effusion

Currently open trials in the same condition.

NCT06421610 — OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion. · Phase 1 · recruiting
NCT05620329 — UNC Pleural Fluid Registry · recruiting

Other Guizhou Medical University trials

Trials by the same sponsor.

NCT07462728 — Phase III, Multicenter, Randomized Controlled Clinical Study of Three-Dimensional Radiotherapy for Primary Tumors in Non · NA · not yet recruiting
NCT07025863 — Intervention Program for Alarm Fatigue in NICU Nurses Based on ABC-X Model · NA · enrolling by invitation
NCT06014450 — Prophylactic Cranial Irradiation Versus Observation in Stage IV NSCLC Randomized Controlled Clinical Study · NA · unknown
NCT05252065 — Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer · unknown
NCT05176067 — Randomized Controlled Clinical Study of Drug Therapy Combined With Thoracic Radiotherapy for Non-oligometastatic NSCLC · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03987087 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Guizhou Medical University
Last refreshed: 14 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03987087.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing